The global home care sleep screening devices market size was valued at USD 3.29 billion in 2023. It is estimated to reach USD 5.84 billion by 2032, growing at a CAGR of 6.6% during the forecast period (2024–2032). In the upcoming years, it is expected that the prevalence of jet lag, narcolepsy, sleepwalking, obstructive sleep apnea, and insomnia among shift workers will increase, driving up demand for sleep monitoring devices. The burgeoning trend towards busier lifestyles, coupled with the widespread adoption of laptops and smartphones, further propels the expansion of this market. Moreover, the escalating demand for home sleep screening devices across pharmacies, retail outlets, online platforms, and various other global applications is a key driver behind the home care sleep screening devices market's growth.
Home sleep screening devices serve as portable instruments designed to monitor individuals' sleep patterns and potentially detect signs of sleep disorders, such as sleep apnea. While they do not provide definitive diagnoses, they offer an invaluable initial step in comprehending one's sleep health. These devices track breathing frequency and potential pauses in breathing (apneas), which are indicative of sleep apnea. They also monitor changes in oxygen levels that often accompany sleep apnea events. By assessing movement patterns, they contribute to evaluating sleep quality and identifying instances of restless sleep, providing users with comprehensive insights into their overall sleep health.
The increasing prevalence of sleep apnea worldwide is anticipated to drive sales of screening devices, such as continuous positive airway pressure (CPAP) machines and sleep monitor rings. Sleep disorders, characterized by symptoms like hypersomnia, insomnia, loud snoring, and morning headaches, necessitate prompt medical attention, fueling demand for effective solutions. The global market is poised for growth due to a surge in new entrants prompted by the escalating prevalence of diverse sleep disorders and the heightened demand for advanced sleep-breathing machines. Moreover, the burgeoning interest in wearable sleep monitoring devices, offering simplicity and convenience for home use, is projected to further propel market expansion.
Furthermore, insufficient sleep is associated with a myriad of negative health and social consequences, including impaired performance in academic and occupational settings. Research indicates that reduced sleep duration correlates with increased risks for various leading causes of death in the U.S., encompassing cardiovascular disease, malignant neoplasms, cerebrovascular disease, accidents, diabetes, septicemia, and hypertension. Consequently, the pervasive impact of inadequate sleep emerges as a pressing public health concern, given its far-reaching effects across multiple domains of health and well-being.
A PSG test is the most trustworthy method for identifying sleep apnea within the lab. They entail spending the night in a sleep lab where various physiological parameters are tracked to get a complete picture of breathing events and sleep patterns. Despite their accessibility and convenience, home care sleep screening devices may not always collect all the information required for a conclusive diagnosis. Home devices may not be as good at capturing certain physiological data points necessary for a full diagnosis as PSG setups in labs.
Patients undergoing home-based testing must sleep in their beds, which may introduce movement artifacts that could impede reliable data collection. Certain pre-existing medical conditions may make it more difficult to interpret the data gathered by at-home screening devices, necessitating additional testing in a lab. Overall, even though home care sleep screening tools are more accessible and convenient than in-lab PSG tests, their lower accuracy can be a major barrier to their wider market adoption.
The introduction of home screening devices presents a more accessible and less disruptive alternative to traditional in-lab sleep studies. Individuals who may have previously postponed testing due to scheduling conflicts or concerns about sleep lab environments, such as claustrophobia, are now more likely to seek evaluation. Early identification of sleep apnea through these devices can lead to prompt intervention and treatment, thereby potentially enhancing patients' overall health and quality of life. Technological advancements have led to the development of increasingly compact and user-friendly home sleep screening devices, further enhancing patient comfort and compliance with testing protocols. This is particularly beneficial for the aging population, among whom sleep apnea is more prevalent. The user-friendly design of these devices makes them a suitable choice for older individuals.
Moreover, recent innovations in multi-modal sensors and technologies have enabled accurate monitoring of physical activity, sleep patterns, and circadian rhythms on a large scale for the first time. These advancements promise to improve the accuracy and accessibility of sleep monitoring, thereby facilitating better management of sleep-related issues. For instance, recent studies have highlighted the substantial economic cost of poor sleep to populations, such as the estimated USD 45.2 billion annual cost to the Australian population. This encompasses direct healthcare expenses, costs associated with related health conditions, decreased productivity, accidents, and informal care provision. Such findings underscore the importance of proactively addressing sleep health issues, with home screening devices playing a pivotal role in this endeavor.
Study Period | 2020-2032 | CAGR | 6.6% |
Historical Period | 2020-2022 | Forecast Period | 2024-2032 |
Base Year | 2023 | Base Year Market Size | USD 3.29 billion |
Forecast Year | 2032 | Forecast Year Market Size | USD 5.84 billion |
Largest Market | North America | Fastest Growing Market | Europe |
Based on region, the global home care sleep screening devices market share is bifurcated into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
North America is the most significant global home care sleep screening devices market shareholder and is expected to expand substantially during the forecast period. The North American market for home sleep screening devices is poised for profitable growth in the coming years, driven by the escalating prevalence of obstructive sleep apnea (OSA), a prevalent sleep-related breathing disorder. According to the American Medical Association (AMA), approximately 6 million Americans have been officially diagnosed with sleep apnea, with an estimated 30 million individuals suffering from the disorder. While OSA is more frequently diagnosed in men, it is also prevalent in women, with rates ranging from 10% to 15% and 15% to 30%, respectively, in North America. The increasing awareness of sleep condition detection and monitoring devices is expected to further bolster market prospects.
Studies indicate that various factors, such as obesity, stress, anxiety, and depression, are closely associated with sleep disorders. In the United States alone, obesity affects approximately 32.2% of men and 35.5% of women, while anxiety and depression collectively impact millions of adults. Insomnia affects 30% of adults, and sleep apnea affects a staggering 22 million people. With such high prevalence rates of sleep disorders across the nation, the demand for sleep screening tools is projected to surge significantly. Moreover, the United States allocates nearly 18% of its GDP, equivalent to USD 3.5 trillion, towards healthcare expenditures, indicating substantial investment in healthcare infrastructure and services.
In Europe, the region emerges as the second most dominant market, holding a substantial 23.2% market share. The United Kingdom stands out with its favorable reimbursement landscape, poised to witness a compound annual growth rate (CAGR) of 4.4% in the sleep screening devices market, signaling promising growth prospects. The European market is expected to be driven by the burgeoning development of innovative sleep monitor rings and anti-snoring devices from established companies and start-ups in the United Kingdom.
Notably, the increasing number of patients in the UK diagnosed with various sleep disorders is expected to fuel demand for sleep monitor rings and similar devices. For instance, Sunrise, a health-tech company in the UK, introduced the first-ever at-home sleep test in April 2021. Priced at £89, the product obviates the need for overnight hospital stays for diagnosis, featuring an AI-powered sensor worn on the chin throughout the night, offering wireless convenience. The rapid development of such tracking devices by numerous UK-based companies is anticipated to further drive home care sleep screening devices market growth in the region.
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
The global home care sleep screening devices market is bifurcated into type, sales channel, and application.
Based on type, the global home care sleep screening devices market is segmented into wearables, non-wearables, sleep monitors, and smart sleep equipment.
The wearable category of the global home sleep screening device market is expected to maintain its leading position. Wearable sleep monitoring devices offer the advantage of convenience and continuous monitoring, allowing individuals to track their sleep patterns without disrupting their nightly routines. These devices typically come in the form of wristbands, rings, or smartwatches equipped with sensors that monitor various sleep metrics, such as movement, heart rate, and oxygen levels. The demand for wearable sleep monitoring devices is expected to increase globally due to their high portability when compared to other product types.
For example, in December 2021, Huawei Technologies Co., Ltd. unveiled the Watch D smartwatch. It offers many cutting-edge features, including heart rate monitoring, blood pressure monitoring, ECG, and sleep tracking. However, users must download the company's unique app to view the tracking results. This new product will assist users in learning about conditions related to their health. Therefore, the growing market for wearable technology is expected to be aided by their accessibility.
Based on sales channels, the global home care sleep screening devices market is segmented into retail stores, online stores, pharmacies, hypermarkets, supermarkets, and others.
The online sales segment owns the highest market share. This growth is expected to be fueled by the extensive range of products available on online retail platforms, including home sleep screening devices and complementary products such as anti-snoring devices. Online sales channels often provide significant discounts compared to physical stores, attracting budget-conscious consumers seeking cost-effective solutions for their sleep health needs. Moreover, the digital nature of online sales channels allows for easier comparison of products, access to customer reviews, and the convenience of shopping from anywhere at any time. This accessibility and transparency enhance consumer confidence and facilitate informed decision-making when purchasing home sleep screening devices online.
Based on application, the global home care sleep screening devices market is bifurcated into insomnia, sleep apnea, narcolepsy, sleep deprivation, circadian rhythm disorders, and others.
The sleep apnea segment dominates the global market. Individuals with diabetes, excessive weight, and structural abnormalities often contribute to the prevalence of sleep apnea. This multifaceted condition has prompted extensive research efforts by various research institutes and pharmaceutical companies worldwide to explore potential treatments and interventions. For instance, the Center Hospitalier Universitaire de Reims initiated a study in November 2021, aiming to investigate cortical activity during functional Magnetic Resonance Imaging (MRI) procedures in patients with awake obstructive sleep apnea syndrome. Such research endeavors seek to deepen our understanding of the underlying mechanisms of sleep apnea and explore novel therapeutic approaches.
As part of steps to control the transmission of the COVID-19 pandemic, governments in several nations have limited the movement of commodities and people and suspended the functioning of manufacturing facilities. It has impacted power usage throughout the world. As per the short-term forecast of the United States Energy Information Administration (EIA), electricity consumption in the United States is expected to fall by a record 4.5% by the end of 2020, as businesses have temporarily shut down due to the government lockdowns to stop the prevalence of the coronavirus. As a result, global demand for and manufacturing instrument transformers is expected to fall.